| 201 |
12610022 | Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. | 2003 Mar |
1 |
| 202 |
12612946 | Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. | 2003 Mar |
1 |
| 203 |
12614193 | ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction? | 2003 Mar |
1 |
| 204 |
12631367 | The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. | 2003 Apr |
1 |
| 205 |
12675278 | Screening and identification of the up-regulated genes in human mesangial cells exposed to angiotensin II. | 2003 Mar |
2 |
| 206 |
12676173 | Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. | 2003 Jun |
2 |
| 207 |
12710529 | Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT1 receptors. | 2003 Feb |
1 |
| 208 |
12716796 | Analysis of metabolic parameters as predictors of risk in the RENAAL study. | 2003 May |
2 |
| 209 |
12733824 | Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium. | 2003 Mar |
1 |
| 210 |
12749912 | Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons. | 2003 Jun |
1 |
| 211 |
12761244 | AngRem104, an angiotensin II-induced novel upregulated gene in human mesangial cells, is potentially involved in the regulation of fibronectin expression. | 2003 Jun |
2 |
| 212 |
12763754 | Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB. | 2003 Sep |
1 |
| 213 |
12811831 | Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. | 2003 Aug |
1 |
| 214 |
12873796 | Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. | 2003 Aug 15 |
1 |
| 215 |
14510783 | Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide. | 2003 Oct |
1 |
| 216 |
14575590 | [Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes and its mechanisms]. | 2003 Sep |
1 |
| 217 |
14652437 | Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetics. | 2003 Sep |
1 |
| 218 |
14669746 | ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. | 2003 May |
1 |
| 219 |
14728071 | Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy. | 2003 |
2 |
| 220 |
14749145 | Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. | 2003 Dec |
2 |
| 221 |
15107595 | Cardiovascular drugs and serum uric acid. | 2003 Sep-Nov |
1 |
| 222 |
11749656 | Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. | 2002 Jan |
1 |
| 223 |
11791032 | Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension. | 2002 Jan |
1 |
| 224 |
11805174 | Variation in the renin angiotensin system throughout the normal menstrual cycle. | 2002 Feb |
1 |
| 225 |
11814138 | Improving the managed care of hypertension with angiotensin II antagonists. | 2002 Jan |
1 |
| 226 |
11824874 | Use of angiotensin II receptor blockers in animal models of atherosclerosis. | 2002 Jan |
1 |
| 227 |
11850771 | Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients. | 2002 Feb |
2 |
| 228 |
11867945 | Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. | 2002 Mar |
1 |
| 229 |
11901904 | [The best of 2001. Arterial hypertension]. | 2002 Jan |
1 |
| 230 |
11963637 | [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data]. | 2002 Jan-Feb |
1 |
| 231 |
11964369 | Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. | 2002 Apr 19 |
1 |
| 232 |
11971755 | Losartan decreases glomerular filtration rate in isolated perfused porcine slaughterhouse kidneys. | 2002 Mar-Apr |
2 |
| 233 |
11973418 | Inhibition of vascular smooth muscle cell growth by angiotensin type 2 receptor stimulation for in vitro organ culture model. | 2002 May |
1 |
| 234 |
11996945 | Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties. | 2002 Jun |
1 |
| 235 |
12021402 | Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. | 2002 Jun |
1 |
| 236 |
12021572 | Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. | 2002 Jun |
2 |
| 237 |
12031795 | Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. | 2002 May 8 |
3 |
| 238 |
12063990 | Effects of losartan, somatostatin and losartan plus somatostatin on portal hemodynamics and renal functions in cirrhosis. | 2002 May-Jun |
1 |
| 239 |
12094823 | The role of losartan in cost-effective hypertension control. | 2002 |
1 |
| 240 |
12119058 | Losartan and diabetic nephropathy: commentaries on the RENAAL study. | 2002 Apr 8 |
1 |
| 241 |
12121010 | Recent landmark clinical trials: how do they modify the therapeutic paradigm? | 2002 Jul |
1 |
| 242 |
12127057 | AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. | 2002 Jul |
3 |
| 243 |
12140723 | AT(1)-receptor blockers: differences that matter. | 2002 Aug |
2 |
| 244 |
12176659 | Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. | 2002 Aug |
4 |
| 245 |
12182249 | The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies. | 2002 Jul |
1 |
| 246 |
12182261 | Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. | 2002 Jul |
1 |
| 247 |
12195129 | Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. | 2002 Sep |
2 |
| 248 |
12208167 | Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. | 2002 Sep |
1 |
| 249 |
12214151 | Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension. | 2002 Mar-Apr |
1 |
| 250 |
12234601 | Antagonist interaction with endogenous AT(1) receptors in human cell lines. | 2002 Oct 15 |
1 |